\
&
Contact us
This was 6 years ago
LocationUniversity Foundation
Egmontstraat 11
1000 Brussels
After a general introduction about proposal writing, we discuss in smaller groups simultaneously per field a Horizon 2020 proposal that has been evaluated by the European Commission in the past, guided by an experienced evaluator and a NCP of this field.
The Horizon 2020 domains for which an interactive workshop will be organised, are
The target public are researchers from companies, universities, research organisations, public institutes, etc. in Belgium, that are less experienced in proposal writing for Horizon 2020 actions but are interested in participating in.
This is in co-organisation with all NCP organisations in Belgium.
For the detailed programme and registration click here
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Digital, Industry & Space Digital Europe
Health Climate, Energy, Mobility Agro-Food, Environment Missions
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.